CXCL13 and neoplasm: Importantly, therapeutic modalities targeting CXCL13-CXCR5 signaling in the tumor microenvironment are currently being explored, although no small molecule pharmacological inhibitors directly targeting CXCL13 or CXCR5 have been yet developed.